Skip to main content
MT

Myris Therapeutics

Inactive

BioHybrid Solutions develops nanoarmored protein-polymer conjugates to enhance the stability and efficacy of therapeutic proteins. This technology addresses the challenges of protein degradation and delivery, improving treatment outcomes in biopharmaceutical applications.

Pittsburgh, United States252K+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Features

  • BioHybrid Solutions develops nanoarmored protein-polymer conjugates to enhance the stability and efficacy of therapeutic proteins. This technology addresses the challenges of protein degradation and delivery, improving treatment outcomes in biopharmaceutical applications.
This profile is AI-generated and may contain inaccuracies.